Construction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets.
Source check: Source checked. Not independent scientific confirmation.
Finding: LASSO, random forest and support-vector-machine feature selection identified six senescence-related genes for a pulmonary-hypertension nomogram. The model had AUC 0.974 in training and was evaluated in external datasets; single-cell RNA sequencing and qPCR in an in-vitro hypoxia model checked core-gene expression. These analyses do not establish clinical diagnostic benefit or therapeutic efficacy.
Technology: LASSO, random forest and support-vector-machine feature selection identified six senescence-related genes for a pulmonary-hypertension diagnostic nomogram, externally tested on separate datasets.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LASSO, random forest and support-vector-machine feature selection identified six senescence-related genes for a pulmonary-hypertension diagnostic nomogram, externally tested on separate datasets.
- Test and result
- The study selected six senescence-related genes for a pulmonary-hypertension diagnostic nomogram, reporting AUC 0.974 in training and results in external datasets. Single-cell RNA sequencing and qPCR in an in-vitro hypoxia model checked core-gene expression; this does not establish clinical diagnostic benefit or therapeutic efficacy.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1038/s41598-025-28921-7
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.